Marina E. Frias-Sanchez
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Metformin improves hepatic steatosis in diet induced obese FVB/N mice: Alterations of glucose metabolism and hepatic splicing machinery.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 11, 2025
Hepatic Artery Atherosclerosis Is a Risk Factor for Biliary Strictures After Liver Transplantation.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 25, 2025
Quantitative proteomic analysis unveils a critical role of VARS1 in hepatocellular carcinoma aggressiveness through the modulation of MAGI1 expression.
Journal: Molecular cancer
Published: October 31, 2024
Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: September 12, 2024
Surgical Navigation and CAD-CAM-Designed PEEK Prosthesis for the Surgical Treatment of Facial Intraosseous Vascular Anomalies.
Journal: Journal of clinical medicine
Published: July 14, 2024
Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features.
Journal: International journal of molecular sciences
Published: May 30, 2024
Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation.
Journal: Clinical transplantation
Published: February 18, 2024
Changes in the Liver Transplant Waiting List after Expanding to the 'Up-to-Seven' Criteria for Hepatocellular Carcinoma.
Journal: Journal of personalized medicine
Published: October 28, 2023
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.
Journal: Molecular oncology
Published: April 14, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach.
Journal: Archives of pathology & laboratory medicine
Published: February 21, 2023
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.
Journal: Molecular therapy. Nucleic acids
Published: February 09, 2023
Last Updated: 09/26/2026